Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,206,857 papers from all fields of science
Search
Sign In
Create Free Account
MK 3207
Known as:
MK-3207
, MK3207
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Characterizing the PK/PD relationship for inhibition of capsaicin-induced dermal vasodilatation by MK-3207, an oral calcitonin gene related peptide receptor antagonist.
Chi-Chung Li
,
Steve Vermeersch
,
+10 authors
J. D. de Hoon
British Journal of Clinical Pharmacology
2015
Corpus ID: 19448391
AIMS Calcitonin gene related peptide (CGRP) receptor antagonists are effective acute migraine treatments. A capsaicin-induced…
Expand
2013
2013
[(11)C]MK-4232: The First Positron Emission Tomography Tracer for the Calcitonin Gene-Related Peptide Receptor.
I. M. Bell
,
S. N. Gallicchio
,
+21 authors
H. Selnick
ACS Medicinal Chemistry Letters
2013
Corpus ID: 31794461
Rational modification of the potent calcitonin gene-related peptide (CGRP) receptor antagonist MK-3207 led to a series of…
Expand
2012
2012
MK-8825: a potent and selective CGRP receptor antagonist with good oral activity in rats.
I. M. Bell
,
C. Stump
,
+17 authors
C. Salvatore
Bioorganic & Medicinal Chemistry Letters
2012
Corpus ID: 32803422
2009
2009
Future drugs for migraine
I. Farinelli
,
S. Filippis
,
G. Coloprisco
,
Serena Missori
,
P. Martelletti
2009
Corpus ID: 26070466
Migraine is a complex, neurovascular disorder in which genetic and environmental factors interact. At present, frontline…
Expand
2009
2009
Blockade of Capsaicin-Induced Dermal Vasodilatation (CIDV) by MK-3207, a Calcitonin-Gene Related Peptide (CGRP) Receptor Antagonist for Acute Treatment of Migraine
W. Kennedy
,
Chi-Chung Li
,
+9 authors
K. Dyck
2009
Corpus ID: 79394900
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required